"The vaccine against coronavirus infection, developed by the Gamaleya Institute, has completed clinical trials," Murashko told reporters, answering a question about whether the clinical trials of the vaccine are officially completed.
Murashko also said that the health ministry expects at least two requests to begin clinical trials in the coming two months.
“We expect at least two more applications in the next one and a half to two months for permission to conduct clinical trials," Murashko said.
He noted that the packet of documents for vaccine registration is being prepared.
